Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionactin binding

ESPN BIN1 ABI3 MAP1A ABI3BP CAMK2B ESPNL PTK2 XIRP2 MICAL2 PLEC AJUBA SAMD14 TNS1

1.76e-0447918714GO:0003779
GeneOntologyMolecularFunctionprotein-macromolecule adaptor activity

CNKSR1 BIN1 ABI3 WWC3 MAP1A RBBP8 OBSL1 PEX6 GRB10 GON4L TUT1 CAMTA2 ATG2A HIF1AN KMT2D BAZ2A ATF7IP TONSL HELZ2 PKN1 DOT1L AJUBA PRDM16 TNS3

2.22e-04116018724GO:0030674
GeneOntologyMolecularFunctionRNA uridylyltransferase activity

TUT4 TUT1

2.60e-0431872GO:0050265
GeneOntologyMolecularFunctionactin filament binding

ESPN BIN1 ABI3 ABI3BP ESPNL XIRP2 PLEC AJUBA SAMD14

2.98e-042271879GO:0051015
GeneOntologyMolecularFunctionmolecular adaptor activity

CNKSR1 BIN1 ABI3 TANK WWC3 MAP1A RBBP8 OBSL1 PEX6 GRB10 GON4L E2F1 TUT1 CAMTA2 ATG2A HIF1AN KMT2D BAZ2A ATF7IP TONSL HELZ2 PKN1 DOT1L AJUBA PRDM16 TNS3

3.91e-04135618726GO:0060090
GeneOntologyCellularComponentcentrosome

CYLD ATF5 CAMK2B OBSL1 RAP1GAP2 E2F1 TESK1 PTK2 IFT52 UBN1 CEP78 CTDP1 ZFYVE26 PPP1R35 AJUBA PLK1 CSPP1 PLK3 MTUS2 CCDC116

2.34e-0577018920GO:0005813
GeneOntologyCellularComponentmicrotubule organizing center

CYLD ATF5 CAMK2B DZIP1L OBSL1 RAP1GAP2 E2F1 TESK1 PTK2 IFT52 MAPK15 UBN1 CEP78 CTDP1 ZFYVE26 PPP1R35 AJUBA PLK1 CSPP1 PLK3 MTUS2 CCDC116

3.11e-0591918922GO:0005815
GeneOntologyCellularComponentdendritic shaft

ABI3 MAP1A ABI3BP ZNF804A GRIP2 SEZ6

5.61e-05741896GO:0043198
GeneOntologyCellularComponentcell leading edge

JCAD ABI3 ABI3BP BCAS3 INPP5E APC2 PLXND1 TESK1 CDC42BPB PTK2 NHS AJUBA PLEKHO1 PHLDB2

1.92e-0450018914GO:0031252
GeneOntologyCellularComponentlamellipodium

ABI3 ABI3BP APC2 PLXND1 TESK1 CDC42BPB PTK2 NHS AJUBA

2.55e-042301899GO:0030027
GeneOntologyCellularComponentdendritic microtubule

MAP1A ZNF804A

4.82e-0441892GO:1901588
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

SEMA6C NDOR1 SETD1B BCAS3 INPP5E RAP1GAP2 PEX6 LAMA5 GRB10 PLXND1 GRIN2D ATG2A TEP1 TESK1 ZDHHC8 CDC42BPB CIC GGA3 KMT2D UBN1 CTDP1 SEC16A HELZ2 ANKRD11 ZFYVE26 PKN1 SNX15 LTBP3 PLEC DOT1L PRDM16 PLK3 PRRT4

2.56e-1511051923335748872
Pubmed

Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.

JCAD ATF5 ACACB MAP1A APC2 ATG2A ZNF804A CIC PTK2 GGA3 ZNF469 FAM193A UBN1 XIRP2 YLPM1 TONSL PRRG4 PLEC AJUBA PLEKHO1

4.38e-134301922035044719
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

CYLD JCAD BCAS3 EXPH5 INPP5E MAP3K14 NELFB GRB10 SRSF11 LARP1B TESK1 CIC ITPKB SAMD11 SEC16A ANKRD11 NHS PLEC PLK1 CSPP1 PHLDB2 TNS3

2.91e-098611922236931259
Pubmed

Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.

CYLD CAD SETD1B MAP1A RBBP8 CAMK2B OBSL1 ZNF318 CIC UBN1 NFATC2IP UBR5 ATF7IP TONSL SEC16A DOT1L

2.02e-075881921638580884
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

BIN1 RBBP8 NELFB ZNF318 CIC URGCP KMT2D KANSL2 UBN1 BAZ2A YLPM1 CTDP1 SEC16A HELZ2 PKN1 PLEC PRRC2A PHLDB2

3.44e-077741921815302935
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

CYLD SETD1B OBSL1 RAP1GAP2 GRB10 GON4L CAMTA2 DCAF5 GGA3 UBR5 BAZ2A SEC16A TET3

4.93e-074071921312693553
Pubmed

Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.

CYLD TOX OBSL1 CDC42BPB UBR5 SEC16A HELZ2 AUTS2 GRIP2 PRDM16

5.57e-072251921012168954
Pubmed

Polo-like kinase is required for synaptonemal complex disassembly and phosphorylation in mouse spermatocytes.

REC8 TEX12 PLK1 PLK3

6.19e-0713192422854038
Pubmed

Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.

TANK MAP1A ZNF318 KMT2D FAM193A UBN1 UBR5 SEC16A PHLDB2

9.39e-07184192932908313
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

CYLD DPYSL2 BIN1 CAD CAMK2B APC2 ZNF318 GRIN2D CDC42BPB PTK2 UBR5 ATF7IP YLPM1 SEC16A PKN1 TNS1 PRRC2A KCNT1 PHLDB2

1.87e-069631921928671696
Pubmed

A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.

CYLD DPYSL2 TUT4 MAP1A BCAS3 LARP1B CDC42BPB PTK2 KIF20A FAM193A CEP78 YLPM1 PLEC MAP2K3 PRRC2A TNS3

3.05e-067241921636232890
Pubmed

A probability-based approach for high-throughput protein phosphorylation analysis and site localization.

CNKSR1 DPYSL2 CAD NELFB GRB10 ANKZF1 NFATC2IP CTDP1 SEC16A NHS PKN1 PRRC2A PHLDB2

5.07e-065031921316964243
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

SEMA6C RALGDS INPP5E LAMA5 PLXND1 ATG2A URGCP GGA3 NRXN3 AUTS2 SDC3 IGSF9 KCNT1

8.68e-065291921314621295
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

ESPN DPYSL2 TUT4 HEBP2 NTF3 BCAS3 CAMK2B GRB10 SRSF11 TEP1 CDC42BPB PTK2 ITPKB GUCY1A1 MICAL2 LMLN ANKRD11 AUTS2 SDC3 IGSF9 PKN1 MAP2K3 TET3

8.92e-0614891922328611215
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

CYLD JCAD CNKSR1 DPYSL2 BIN1 APC2 OBSL1 RAP1GAP2 HUNK CDC42BPB DCAF5 PTK2 KANSL2 MICAL2 TPP1 YLPM1 LTBP3 PLEC OLIG2 PRRC2A MTUS2

9.75e-0612851922135914814
Pubmed

Genomic analysis of mouse retinal development.

ROBO4 RALGDS BIN1 CDHR1 GRB10 IRF3 PTK2 KANSL2 BAZ2A CARF TONSL IGSF9 ZFYVE26 PLEC PLK1 SAMD14 MTUS2 SEZ6

1.33e-0510061921815226823
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

CYLD IL16 TUT4 MAP1A GPT OBSL1 PEX6 ZNF318 TEP1 DCAF5 KIF20A ZNF469 ARHGEF33 C1orf226 UBR5 BAZ2A SEC16A PRDM16 PHLDB2

1.51e-0511161921931753913
Pubmed

The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.

INPP5E CDC42BPB UBN1 SEC16A HELZ2 ANKRD11 PLEC AP4M1 PRRC2A TNS3

1.75e-053321921037433992
Pubmed

A human MAP kinase interactome.

RALGDS MAP1A ABI3BP EXPH5 RAP1GAP2 LCP2 CDC42BPB CIC PTK2 ATF7IP PLEC TNS1

1.85e-054861921220936779
Pubmed

Interactomes of Glycogen Synthase Kinase-3 Isoforms.

CYLD MAP1A LARP1B FAM193A UBR5 SEC16A NHS TNS3

2.28e-05209192836779422
Pubmed

Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.

DPYSL2 BIN1 MAP1A BCAS3 CAMK2B PTK2 PRRT3 PLEC SAMD14 PRRC2A

2.56e-053471921017114649
Pubmed

PLK1 targets CtIP to promote microhomology-mediated end joining.

RBBP8 PLK1

3.03e-052192230202980
Pubmed

Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors.

AJUBA PLK1

3.03e-052192228126323
Pubmed

Phosphorylation of mitotic kinesin-like protein 2 by polo-like kinase 1 is required for cytokinesis.

KIF20A PLK1

3.03e-052192212939256
Pubmed

Characterization of the human IRF-3 promoter and its regulation by the transcription factor E2F1.

E2F1 IRF3

3.03e-052192219826915
Pubmed

MRCKβ links Dasm1 to actin rearrangements to promote dendrite development.

CDC42BPB IGSF9

3.03e-052192233933448
Pubmed

Tensin Regulates Fundamental Biological Processes by Interacting with Integrins of Tonsil-Derived Mesenchymal Stem Cells.

TNS1 TNS3

3.03e-052192235954177
Pubmed

The c-MYC-interacting proapoptotic tumor suppressor BIN1 is a transcriptional target for E2F1 in response to DNA damage.

BIN1 E2F1

3.03e-052192219629135
Pubmed

Cloning and sequencing of a novel human gene that encodes a putative target protein of Nesh-SH3.

ABI3 ABI3BP

3.03e-052192211501947
Pubmed

Polo box domain of Plk3 functions as a centrosome localization signal, overexpression of which causes mitotic arrest, cytokinesis defects, and apoptosis.

PLK1 PLK3

3.03e-052192216478733
Pubmed

A novel m6A reader Prrc2a controls oligodendroglial specification and myelination.

OLIG2 PRRC2A

3.03e-052192230514900
Pubmed

Polo-like kinase 3 regulates CtIP during DNA double-strand break repair in G1.

RBBP8 PLK3

3.03e-052192225267294
Pubmed

Direct repression of the human IRF-3 promoter by E2F1.

E2F1 IRF3

3.03e-052192221225257
Pubmed

The dissociation of cohesin from chromosomes in prophase is regulated by Polo-like kinase.

PLK1 PLK3

3.03e-052192211931760
Pubmed

Unique subcellular distribution of phosphorylated Plk1 (Ser137 and Thr210) in mouse oocytes during meiotic division and pPlk1(Ser137) involvement in spindle formation and REC8 cleavage.

REC8 PLK1

3.03e-052192226654596
Pubmed

The E3 ubiquitin ligase UBR5 regulates centriolar satellite stability and primary cilia.

UBR5 CSPP1

3.03e-052192229742019
Pubmed

The tumor suppressor CYLD regulates entry into mitosis.

CYLD PLK1

3.03e-052192217495026
Pubmed

Knockout of the gene encoding the extracellular matrix protein SNED1 results in early neonatal lethality and craniofacial malformations.

E2F1 SNED1

3.03e-052192233012048
Pubmed

Repression of interferon regulatory factor 3 by the Epstein-Barr virus immediate-early protein Rta is mediated through E2F1 in HeLa cells.

E2F1 IRF3

3.03e-052192224535579
Pubmed

G protein-coupled receptor activation rapidly stimulates focal adhesion kinase phosphorylation at Ser-843. Mediation by Ca2+, calmodulin, and Ca2+/calmodulin-dependent kinase II.

CAMK2B PTK2

3.03e-052192215845548
Pubmed

USP45 and Spindly are part of the same complex implicated in cell migration.

DPYSL2 TUT4 CAD ABI3BP RBBP8 PLXND1 UBR5 PLEC

5.25e-05235192830258100
Pubmed

Comprehensive binary interaction mapping of SH2 domains via fluorescence polarization reveals novel functional diversification of ErbB receptors.

GRB10 LCP2 SHD TNS1 TNS3

6.97e-0577192522973453
Pubmed

Proximity labeling reveals dynamic changes in the SQSTM1 protein network.

TUT4 BCAS3 OBSL1 FAM193A SEC16A AUTS2 PKN1 PLK1 CSPP1

8.22e-05322192939098523
Pubmed

Genomic alterations and evolution of cell clusters in metastatic invasive micropapillary carcinoma of the breast.

IGSF9 PRDM16

9.06e-053192235013309
Pubmed

Loss of Capicua alters early T cell development and predisposes mice to T cell lymphoblastic leukemia/lymphoma.

NDOR1 CIC

9.06e-053192229382756
Pubmed

BRCA1-induced large-scale chromatin unfolding and allele-specific effects of cancer-predisposing mutations.

RBBP8 NELFB

9.06e-053192211739404
Pubmed

p53 Suppresses E2F1-dependent PLK1 expression upon DNA damage by forming p53-E2F1-DNA complex.

E2F1 PLK1

9.06e-053192224076372
Pubmed

Plk3 phosphorylates topoisomerase IIalpha at Thr(1342), a site that is not recognized by Plk1.

PLK1 PLK3

9.06e-053192218062778
Pubmed

The Deubiquitinase OTUB1 Is a Key Regulator of Energy Metabolism.

NDOR1 HIF1AN

9.06e-053192235163456
Pubmed

Dynamic coregulatory complex containing BRCA1, E2F1 and CtIP controls ATM transcription.

RBBP8 E2F1

9.06e-053192222832221
Pubmed

Loss of tonic T-cell receptor signals alters the generation but not the persistence of CD8+ memory T cells.

NDOR1 LCP2

9.06e-053192220884806
Pubmed

Growth hormone stimulates the tyrosine phosphorylation and association of p125 focal adhesion kinase (FAK) with JAK2. Fak is not required for stat-mediated transcription.

PTK2 TNS1

9.06e-05319229553131
Pubmed

Homeostatic division is not necessary for antigen-specific CD4+ memory T cell persistence.

NDOR1 LCP2

9.06e-053192222956580
Pubmed

The ALDH2, IGSF9, and PRDM16 Proteins as Predictive Biomarkers for Prognosis in Breast Cancer.

IGSF9 PRDM16

9.06e-053192236639264
Pubmed

Inducible transgenic expression of tripeptidyl peptidase 1 in a mouse model of late-infantile neuronal ceroid lipofuscinosis.

NDOR1 TPP1

9.06e-053192229408933
Pubmed

Tumor suppressor CYLD regulates acute lung injury in lethal Streptococcus pneumoniae infections.

CYLD MAP2K3

9.06e-053192217723219
Pubmed

T-cell receptor signals direct the composition and function of the memory CD8+ T-cell pool.

NDOR1 LCP2

9.06e-053192220847203
Pubmed

Oral ivermectin as an unexpected initiator of CreT2-mediated deletion in T cells.

NDOR1 LCP2

9.06e-053192222344272
Pubmed

Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.

CYLD ACACB NELFB ZNF318 PLXND1 CDC42BPB MFF KIF20A LIPE UBR5 ATF7IP SEC16A PKN1 AP4M1

1.16e-047771921435844135
Pubmed

Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.

ACACB RBBP8 ZNF318 CIC KMT2D FAM193A UBR5 ATF7IP SEC16A PLEC

1.20e-044181921034709266
Pubmed

Human transcription factor protein interaction networks.

CYLD CAD ACACB GON4L E2F1 IRF3 ZNF318 DCAF5 CIC KMT2D KANSL2 UBN1 SAMD11 ATF7IP YLPM1 SEC16A AUTS2 DOT1L PRDM16 PRRC2A

1.36e-0414291922035140242
Pubmed

Regulatory T cells require TCR signaling for their suppressive function.

NDOR1 LCP2

1.81e-044192225821220
Pubmed

Stereocilia-staircase spacing is influenced by myosin III motors and their cargos espin-1 and espin-like.

ESPN ESPNL

1.81e-044192226926603
Pubmed

Mislocalization of SLP-76 leads to aberrant inflammatory cytokine and autoantibody production.

NDOR1 LCP2

1.81e-044192220029045
Pubmed

Identification and assessment of PLK1/2/3/4 in lung adenocarcinoma and lung squamous cell carcinoma: Evidence from methylation profile.

PLK1 PLK3

1.81e-044192234080290
Pubmed

NIK is a component of the EGF/heregulin receptor signaling complexes.

MAP3K14 GRB10

1.81e-044192212853971
Pubmed

Tensin3 is a negative regulator of cell migration and all four Tensin family members are downregulated in human kidney cancer.

TNS1 TNS3

1.81e-044192219194507
Pubmed

Epidermal growth factor modulates tyrosine phosphorylation of a novel tensin family member, tensin3.

PTK2 TNS3

1.81e-044192215140944
Pubmed

Regulation of E2F1-induced apoptosis by poly(ADP-ribosyl)ation.

BIN1 E2F1

1.81e-044192225257171
Pubmed

Mutations in Mll2, an H3K4 methyltransferase, result in insulin resistance and impaired glucose tolerance in mice.

NDOR1 KMT2D

1.81e-044192223826075
Pubmed

The scaffold protein TANK/I-TRAF inhibits NF-kappaB activation by recruiting polo-like kinase 1.

TANK PLK1

1.81e-044192220484576
Pubmed

Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.

BIN1 E2F1

1.81e-044192218348166
Pubmed

Phosphorylation of threonine 68 promotes oligomerization and autophosphorylation of the Chk2 protein kinase via the forkhead-associated domain.

PLK1 PLK3

1.81e-044192211901158
Pubmed

Conditional deletion of SLP-76 in mature T cells abrogates peripheral immune responses.

NDOR1 LCP2

1.81e-044192221469089
Pubmed

Repair of noise-induced damage to stereocilia F-actin cores is facilitated by XIRP2 and its novel mechanosensor domain.

NDOR1 XIRP2

1.81e-044192237294664
Pubmed

Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.

CYLD JCAD ACACB NELFB FAM193A UBR5 SEC16A PLK1 CSPP1 PHLDB2

2.03e-044461921024255178
Pubmed

A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.

CYLD BCAS3 RAP1GAP2 GRB10 IRF3 ATG2A ANKZF1 HIF1AN KIF20A CEP78 UBR5 SEC16A PPP1R35 AP4M1 AJUBA TNS3

2.26e-0410381921626673895
Pubmed

DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation.

ATF5 MAP1A ATF7IP

2.36e-0422192312812986
Pubmed

BAG5 Promotes Alpha-Synuclein Oligomer Formation and Functionally Interacts With the Autophagy Adaptor Protein p62.

DPYSL2 MAP1A ZNF318 SEC16A PLEC TNS3

2.40e-04156192632850835
Pubmed

Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.

JCAD CAD GRAMD1A CDC42BPB CIC KMT2D C1orf226 YLPM1 SEC16A NHS AJUBA PLK1 CSPP1 TNS1 PRRC2A TNS3

2.55e-0410491921627880917
Pubmed

SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.

DPYSL2 CAD ZNF318 GGA3 KMT2D BAZ2A YLPM1 SEC16A DOT1L PLK1 PRRC2A

2.58e-045491921138280479
Pubmed

Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillance.

ACACB MAP1A SRSF11 UBR5 YLPM1 TONSL SNX15

2.76e-04226192731452512
Pubmed

Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.

RALGDS OBSL1 PEX6 GON4L SRSF11 COLGALT2 ANKZF1 URGCP PTK2 CEP78 TPP1 TONSL

2.87e-046501921238777146
Pubmed

A protein-protein interaction map of the TNF-induced NF-κB signal transduction pathway.

CYLD TANK CAMK2B OBSL1 YOD1 YLPM1 PLEC PRRC2A

2.93e-04302192830561431
Pubmed

Inactivation of tensin3 in mice results in growth retardation and postnatal lethality.

TNS1 TNS3

3.00e-045192215733665
Pubmed

Structural and functional analyses of minimal phosphopeptides targeting the polo-box domain of polo-like kinase 1.

PLK1 PLK3

3.00e-045192219597481
Pubmed

The phosphotyrosine-independent interaction of DLC-1 and the SH2 domain of cten regulates focal adhesion localization and growth suppression activity of DLC-1.

TNS1 TNS3

3.00e-045192217190795
Pubmed

Mutant p53 perturbs DNA replication checkpoint control through TopBP1 and Treslin.

TICRR E2F1

3.00e-045192228439015
Pubmed

A gene affecting Wallerian nerve degeneration maps distally on mouse chromosome 4.

ESPN FUCA1

3.00e-04519228415768
Pubmed

Phosphorylation of synucleins by members of the Polo-like kinase family.

PLK1 PLK3

3.00e-045192219889641
Pubmed

A TRAF3-NIK module differentially regulates DNA vs RNA pathways in innate immune signaling.

MAP3K14 IRF3

3.00e-045192230018345
Pubmed

TACI induces cIAP1-mediated ubiquitination of NIK by TRAF2 and TANK to limit non-canonical NF-kappaB signaling.

TANK MAP3K14

3.00e-045192220184394
Pubmed

Prickle1 promotes focal adhesion disassembly in cooperation with the CLASP-LL5β complex in migrating cells.

PRICKLE1 PHLDB2

3.00e-045192227378169
Pubmed

Identification of TBK1 complexes required for the phosphorylation of IRF3 and the production of interferon β.

TANK IRF3

3.00e-045192228159912
Pubmed

Polo-like kinase 1 and Chk2 interact and co-localize to centrosomes and the midbody.

PLK1 PLK3

3.00e-045192212493754
Pubmed

PLK1-mediated phosphorylation of PPIL2 regulates HR via CtIP.

RBBP8 PLK1

3.00e-045192236092721
Pubmed

Structural insights into the functions of TBK1 in innate antimicrobial immunity.

TANK IRF3

3.00e-045192223746807
Pubmed

The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response.

TANK IRF3

3.00e-045192218583960
Pubmed

PRRG4 promotes breast cancer metastasis through the recruitment of NEDD4 and downregulation of Robo1.

PTK2 PRRG4

3.00e-045192233037408
Pubmed

Mammalian Polo-like kinase 3 (Plk3) is a multifunctional protein involved in stress response pathways.

PLK1 PLK3

3.00e-045192212242661
InteractionTOP3B interactions

SEMA6C CAD NDOR1 SETD1B BCAS3 INPP5E PLEKHA4 RAP1GAP2 PEX6 LAMA5 GRB10 PLXND1 GRIN2D ATG2A TEP1 TESK1 ZDHHC8 CDC42BPB CIC GGA3 KMT2D UBN1 CTDP1 SEC16A HELZ2 ANKRD11 ZFYVE26 PKN1 SNX15 LTBP3 PLEC DOT1L PRDM16 PRRC2A PLK3 PRRT4

5.16e-08147018536int:TOP3B
InteractionYWHAG interactions

CYLD JCAD TICRR CAD BCAS3 EXPH5 INPP5E DZIP1L PLEKHA4 NELFB GRB10 SRSF11 LARP1B TESK1 ANKRD55 CIC PTK2 ITPKB GRID2IP CEP78 SAMD11 SEC16A ANKRD11 NHS PLK1 CSPP1 PHLDB2 TNS3

1.03e-05124818528int:YWHAG
InteractionDCAF4 interactions

TUT4 SETD1B ACACB E2F1 ATG2A LARP1B ZDHHC8 DCAF5 FAM193A UBR5 BAZ2A SEC16A HELZ2 PHLDB2

1.10e-0537818514int:DCAF4
InteractionMAD2L1 interactions

CAD PLEKHA4 E2F1 ZNF318 DCAF5 CIC KIF20A UBR5 ATF7IP CTDP1 MAP2K3

2.23e-0525218511int:MAD2L1
Cytoband9q34.3

RALGDS NDOR1 ARRDC1-AS1 INPP5E SEC16A KCNT1

5.96e-0610619269q34.3
GeneFamilyZinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family

SETD1B KMT2D DOT1L PRDM16

5.61e-05341124487
GeneFamilyProline rich transmembrane proteins

PRRT3 PRRT4

2.26e-0441122688
GeneFamilySH2 domain containing

GRB10 LCP2 SHD TNS1 TNS3

4.12e-041011125741
GeneFamilyFibronectin type III domain containing

ROBO4 ABI3BP SNED1 ATF7IP IGSF9 ROS1

4.83e-041601126555
GeneFamilyLIM domain containing

PRICKLE1 XIRP2 MICAL2 AJUBA

4.89e-045911241218
GeneFamilyNon-canonical poly(A) polymerases

TUT4 TUT1

7.83e-04711221318
GeneFamilyDNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing

TNS1 TNS3

1.04e-0381122837
GeneFamilyAnkyrin repeat domain containing

ESPN ESPNL ANKZF1 ANKRD55 TONSL ANKRD11

3.97e-032421126403
CoexpressionDEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN

JCAD CAD OBSL1 LAMA5 FTSJ1 ATG2A ITPKB SEC16A FUCA1 PLEC MAP2K3

5.67e-0627618911M3063
CoexpressionGSE12845_IGD_POS_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_UP

INPP5E RAP1GAP2 ANKZF1 LIPE SULT2B1 TPP1 ROS1 PLEC MTUS2

1.34e-051961899M3189
CoexpressionGSE27786_LIN_NEG_VS_NEUTROPHIL_DN

EMB INPP5E ATG2A HUNK CIC KMT2D SLC34A1 FAM217B PLEC

1.57e-052001899M4795
CoexpressionLINDGREN_BLADDER_CANCER_CLUSTER_2B

DPYSL2 IL16 TOX MAP1A ABI3BP PRICKLE1 LCP2 PTK2 GUCY1A1 MICAL2 SDC3 TNS1

2.78e-0538918912M4995
CoexpressionMILI_PSEUDOPODIA_CHEMOTAXIS_UP

ATF5 DCAF5 MFF ANKRD11 PKN1 PHLDB2

3.31e-05841896M15130
CoexpressionMILI_PSEUDOPODIA_CHEMOTAXIS_UP

ATF5 DCAF5 MFF ANKRD11 PKN1 PHLDB2

3.78e-05861896MM825
ToppCellHippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)|Hippocampus / BrainAtlas - Mouse McCarroll V32

REC8 SEMA6C GRIN2D ANKRD55 NRXN3 NHS GRIP2 PRRT4

7.38e-071691928c135d7ae0490d0024e0f4bd8c4ad42f6674a61da
ToppCellHippocampus-Neuronal-Inhibitory|Hippocampus / BrainAtlas - Mouse McCarroll V32

REC8 SEMA6C GRIN2D ANKRD55 NRXN3 UBR5 NHS GRIP2

1.29e-061821928b54ae650c04dfd0759c5f5e752b9bf684dd36516
ToppCellfacs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TRABD2B ATF5 ZBTB7C LAMA5 YOD1 DOT1L TNS1 PHLDB2

1.46e-06185192838486b69c48dc5e1c4e1488208fa8954a973eccb
ToppCellfacs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TRABD2B ATF5 ZBTB7C LAMA5 YOD1 DOT1L TNS1 PHLDB2

1.46e-0618519283c28b5ceba3cfdb6f7e32d5b42e03b6a81a7a658
ToppCellpdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

JCAD ZBTB7C EXPH5 GRAMD1A LAMA5 HUNK NRXN3 NHS

1.58e-0618719287e376831a11ee72ed87abcdac631ca46ae29c250
ToppCellTCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4|TCGA-Prostate / Sample_Type by Project: Shred V9

TRABD2B ACACB MAP3K14 ZNF469 LIPE NHS LTBP3 AJUBA

2.16e-0619519285562665dd3beb70e2358aa32611a337bef5731c1
ToppCellEpithelial_cells-AT1-AT2_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id

ABI3BP LAMA5 HCFC1R1 AJUBA PLEKHO1 TNS1 PHLDB2 TNS3

2.42e-061981928fbc46b20bcd44f2083170aacbc6f5dd00fba685c
ToppCellTCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma|TCGA-Colorectal / Sample_Type by Project: Shred V9

CAD GRAMD1A FTSJ1 E2F1 SLC12A8 GRIN2D KIF20A AJUBA

2.51e-06199192885b3b1ad01368dae4adbc9da7efc148e49992f69
ToppCellTCGA-Colorectal-Primary_Tumor|TCGA-Colorectal / Sample_Type by Project: Shred V9

CAD GRAMD1A FTSJ1 E2F1 SLC12A8 GRIN2D KIF20A AJUBA

2.51e-061991928c7d6a8398f2419b726a0461585d1ee0561654e3b
ToppCell367C-Lymphocytic-CD4_T-cell-Treg_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

NEURL2 TOX C2CD4A MAPK15 TPP1 NHS IGSF9

4.43e-0615219276d02b50e9e9ecf820f84a79e46d153a4840a1cfe
ToppCellHippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Hippocampus / BrainAtlas - Mouse McCarroll V32

REC8 SEMA6C GRIN2D NRXN3 UBR5 NHS GRIP2

6.47e-061611927b81b346309f3facbfbebd91cae4c5b33c7bd24ef
ToppCellfacs-Pancreas-Exocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ATF5 CDHR1 DZIP1L ANKZF1 ZDHHC8 CIC MAPK15

7.30e-061641927b895674ed2df87db8fbfb30b7e31620945588491
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SEMA6C ROBO4 ERFL AQP7B PLXND1 LCP2 PLK1

7.90e-061661927ec719368295133da2f7ff587c5329ed6db1dd56d
ToppCellPND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TRABD2B MAP1A NTF3 GUCY1A1 TONSL NHS GRIP2

8.22e-061671927784776d1fcc098f84d3c2eca58fa56cb9428f434
ToppCellPND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ROBO4 C14orf93 HEBP2 SLC12A8 PLXND1 KANSL2 C1orf226

1.03e-0517319274968712af1cca8c932abd3323631d7dcaffd4a66
ToppCelldroplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l7|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ROBO4 ACACB PLXND1 LIPE NPW SBK3 SEZ6

1.12e-0517519277be76d39e1a4f4ac709672cd2d409a2523a083ce
ToppCellCOVID-19_Mild-Neu_3|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients

MAP1A GON4L HIF1AN KMT2D NHS PKN1 TNS3

1.16e-0517619272049767fd591045cfcf5b1071d80798e52843f27
ToppCell3'-Child04-06-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LAMA5 TUT1 GUCY1A1 GRIP2 TNS1 KCNT1 PHLDB2

1.16e-05176192790f36f10c6ed440a0ca549f23219398853f1fbc3
ToppCell368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)

TICRR NDOR1 RBBP8 ESPNL C1orf226 GUCY1A1 PLK1

1.20e-051771927844017225e9039d1bc621a9630a30c2e9a51b36d
ToppCell3'-Adult-LargeIntestine-Hematopoietic-T_cells-SELL+_CD4_T|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

BIN1 IL16 LCP2 ANKZF1 ANKRD55 PLK3 SEZ6

1.20e-051771927bb496fbec7cacc52847abe2b2714249c47879763
ToppCelldroplet-Bladder-Unstain-18m-Epithelial-granulocyte-monocyte_progenitor|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

REC8 TICRR E2F1 C2CD4A KIF20A SAMD11 PLK1

1.29e-051791927804aa3899585fc7e662eff9f6d41f48655f16dd6
ToppCelldroplet-Heart-HEART-1m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ROBO4 GPT MAP3K14 PLXND1 SHD TONSL PRDM16

1.29e-051791927dd94ebe69ade6f51b94058abe066216f0de9feda
ToppCellfacs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

C14orf93 ACACB ABI3BP PLXND1 TXLNB GUCY1A1 PRRT4

1.34e-0518019272d608b9394d28d19cfc85c6ac94003d5177c8a92
ToppCell10x5'-lymph-node_spleen-Myeloid_Mac-Cycling_Myeloid-Mac|lymph-node_spleen / Manually curated celltypes from each tissue

DZIP1L CCL27 KIF20A C1orf226 SDC3 PLK1 TNS3

1.34e-0518019274eea8366cdb82c356325ce88f09ad8b302c17a07
ToppCellfacs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

C14orf93 ACACB ABI3BP PLXND1 TXLNB GUCY1A1 PRRT4

1.34e-051801927baa5825e6ce23a98d9c21d024a4b0ab8ba353d0c
ToppCellfacs-Lung-24m-Endothelial-arterial_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

C14orf93 ACACB ABI3BP PLXND1 TXLNB GUCY1A1 PRRT4

1.34e-0518019270f9b27054358c4737eed06c8ea01987cccc3cb55
ToppCellHealthy_Control-Lymphoid-NK|Healthy_Control / Condition, Lineage, Cell class and cell subclass

JCAD TOX EMB CDHR1 SLC34A1 SPON2 AUTS2

1.49e-051831927b41b1f32022c8632a638cf1c5523c9a24176f568
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

NTF3 GRIN2D ANKRD55 NHS GRIP2 NPW PRRT4

1.49e-051831927e3ffef2b57dc5b96466dccc9cd54ba326ccf378a
ToppCelldroplet-Liver-Hepatocytes-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

JCAD CAD NDOR1 ABI3BP PRICKLE1 CDC42BPB TNS3

1.65e-05186192737860daeecd6d412bd3797f30496a56da667fbd1
ToppCell10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

DPYSL2 ASPHD1 GRB10 PLXND1 SDC3 TNS1 SECTM1

1.65e-051861927f73cb91e74a806858650ae97f543fc779ba4cff8
ToppCelldroplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

JCAD CAD NDOR1 ABI3BP PRICKLE1 CDC42BPB TNS3

1.65e-05186192760830822d3de3147816693404fd03392e04c2b8e
ToppCelldroplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

JCAD CAD NDOR1 ABI3BP PRICKLE1 CDC42BPB TNS3

1.65e-051861927baebeffdd426ce767190ddefc857cc78e6a58d36
ToppCell10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

DPYSL2 ASPHD1 GRB10 PLXND1 SDC3 TNS1 SECTM1

1.65e-0518619278694ca16c9780729f4fba67ba20e35745f1eb4e9
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ABCA3 TOX NRXN3 MICAL2 AUTS2 ROS1 PRDM16

1.65e-051861927e83718fabb057100835d3357df407f283d23fe16
ToppCell3'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

JCAD ROBO4 IL16 ABI3 PLXND1 ITPKB PKN1

1.71e-05187192750d5730e2cd4951d3ad0641fc81ae9f6ddabafe7
ToppCellE18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass

TRABD2B ABI3BP GRB10 GUCY1A1 SPON2 TNS1 TNS3

1.83e-0518919270c18d3de4720759cf802eefb4d0ddde2a9246a1a
ToppCelldroplet-Heart|droplet / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

JCAD DPYSL2 ABI3 PLXND1 GUCY1A1 PLEKHO1 TNS1

2.03e-05192192767a7e07a11091120edbccf739836235c422ec9c6
ToppCellPrimary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

GRIN2D HUNK LCP2 ANKRD55 NHS GRIP2 PRRT4

2.03e-05192192767d6230e32d446dcb12047fae2c3f1faa80dd720
ToppCellLPS-IL1RA-Endothelial-Endothelial-Vein|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SEMA6C ABI3 ZBTB7C PLXND1 SAMD11 NPW FAM181B

2.03e-051921927717f3d3bbee4d0f64ba1341ee2b00a407ba1e0f3
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

ABI3 RAP1GAP2 CEP78 SPON2 AUTS2 MAP2K3 SERTAD3

2.17e-05194192724837a27b0041fe8c348225fa8b09b127d743603
ToppCell10x5'-bone_marrow-Hematopoietic_progenitors-HSC-MPP|bone_marrow / Manually curated celltypes from each tissue

ROBO4 OBSL1 GRB10 E2F1 GUCY1A1 NPW PRRT4

2.17e-0519419273a7e7acbddc63da44d9a04a5b52adf6934fc83dd
ToppCellBronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

TRABD2B NTF3 PLEKHA4 NHS GRIP2 ENPEP PHLDB2

2.47e-051981927f261a37dd07976548b897af86df1d1a0dc069889
ToppCellTracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

LAMA5 GRIP2 PRDM16 TNS1 ENPEP KCNT1 PHLDB2

2.47e-0519819277dd874b09c81cc512ccc1e9b65f290a5f94d736e
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

ABI3 TOX RAP1GAP2 CEP78 SPON2 AUTS2 SERTAD3

2.47e-051981927faeef749a4b4bdc7f3edb6923e0e248e8b92c9d0
ToppCellSepsis-Leuk-UTI-Lymphocyte-T/NK-CD4+_CTL|Leuk-UTI / Disease, condition lineage and cell class

TOX EMB CAMK2B COLGALT2 CEP78 SPON2 AUTS2

2.55e-051991927b2609f9d716fdd04f35f0da7f8995d28d7df431d
ToppCellNeuronal-Inhibitory-iB|Neuronal / cells hierarchy compared to all cells using T-Statistic

GRIN2D HUNK ANKRD55 NRXN3 NHS GRIP2 PRRT4

2.64e-05200192745ddc5ef2caa87ada88327b63ba9b150a6bb3aa5
ToppCellprimary_visual_cortex-Neuronal-glutamatergic_neuron-NP|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

IL16 TRABD2B TOX ABI3BP CDHR1 PHLDB2

5.17e-051521926b6a7453fbf9f898e4f222b215907c9a110baa2f6
ToppCell367C-Lymphocytic-CD4_T-cell-Treg_cell_4|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)

ROBO4 TOX C2CD4A MAPK15 TPP1 IGSF9

5.17e-051521926eb7ff36792c3c54ac88cfe976f84016b70b1a1d7
ToppCellP28-Epithelial-epithelial_progenitor_cell-epi_progenitor|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

REC8 EMB MISP3 NPW NALF2 MTUS2

5.76e-051551926be575a0096415705dba425002247289ff8f89474
ToppCell5'-Adult-Appendix-Hematopoietic-B_cells-Cycling_B_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CAMK2B APC2 E2F1 ZNF318 ZNF804A UBR5

5.97e-051561926203ef22eb76bd2b829b027c30af0557080f4006c
ToppCellChildren_(3_yrs)-Epithelial-basal_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

ABI3BP NTF3 LAMA5 PTK2 SULT2B1 NHS

6.18e-0515719266ee2692f705bdd93ba523dffaf2f0cd921b47e28
ToppCellwk_15-18-Epithelial-Proximal_epithelial-basal_intermediate_|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

ABCA3 ASPHD1 EXPH5 NRXN3 GRID2IP IGSF9

6.40e-05158192698712ed7e8e65e8c5ff9318cf0e0a04e271a055d
ToppCellBAL-Severe-cDC_4|Severe / Compartment, Disease Groups and Clusters

ZBTB7C ACACB INPP5E GPT MISP3 NHS

6.40e-05158192673f66689ef59f71b14cb7141ca5951cc47fe57c1
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

JCAD ROBO4 EMB E2F1 GRIN2D TMEM121

6.87e-051601926830e3ef8c9708d25872c3052a0b2682fa9372111
ToppCellkidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

JCAD ROBO4 E2F1 PLXND1 NPW ERICH6

7.87e-0516419261592a5becad7e0f3f990f0d7581d75fcfc7da023
ToppCell10x5'-Liver-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|Liver / Manually curated celltypes from each tissue

TICRR NEURL2 DZIP1L KIF20A NHS PLK1

8.41e-051661926a176e87aa6eec81d1fb79a028f759182d11b567d
ToppCell10x5'-Liver-Hematopoietic_progenitors|Liver / Manually curated celltypes from each tissue

TICRR NEURL2 DZIP1L KIF20A NHS PLK1

8.41e-051661926ae967570248cf86ca3ddf55e33bcbb3e4e3684bc
ToppCellIonocyte-iono-3|World / Class top

RAP1GAP2 GRB10 ZNF318 LARP1B FAM217B PLK1

8.41e-0516619269c4a780f8af46d7552077c7a0ae0ab1b2413e5d4
ToppCellfacs-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

IL16 TOX GRAMD1A LCP2 TXLNB TONSL

8.99e-0516819266c758eb120faf06ff72d157b495e399191c79ec9
ToppCellBAL-Control-cDC_6|Control / Compartment, Disease Groups and Clusters

MAP1A KIF20A RCC1L NFATC2IP SAMD14 SEZ6

8.99e-05168192665ec473cff748b334c0a66e33bc34a8465fe7631
ToppCellControl|World / group, cell type (main and fine annotations)

ABCA3 TOX EXPH5 NRXN3 MICAL2 ROS1

8.99e-051681926a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCelldroplet-Lung-LUNG-1m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TEP1 ANKRD55 NEURL3 SLC34A1 SDC3 PLEKHO1

9.29e-051691926735655e75511c5c41aca667909e8bb52a0ad7fc6
ToppCellFrontal_cortex-Neuronal-Inhibitory|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

SEMA6C GRIN2D ANKRD55 NRXN3 NHS GRIP2

9.29e-05169192678eb70dd916724e476eabccf18fb7fcec4210308
ToppCellPND01-03-samps-Mesenchymal-Pericyte-pericyte_F|PND01-03-samps / Age Group, Lineage, Cell class and subclass

CAD HUNK SHD GUCY1A1 FAM181B AJUBA

9.59e-05170192671718dcebd48105994c313bb55babc70301170a0
ToppCellGlobus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

TRABD2B ATF5 NTF3 TXLNB ENPEP PHLDB2

1.06e-04173192651328a60ffaf34fa0f7df6084d348b5efc9917f5
ToppCell5'-Adult-SmallIntestine-Epithelial-neuro-epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ASPHD1 CAMK2B NPW FAM181B MTUS2 SEZ6

1.06e-04173192630fa8c14c8a1f546f380132c0c28a61e6a2f9fc4
ToppCelldroplet-Heart-4Chambers-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ROBO4 ABI3 ESPNL PLXND1 ITPKB LIPE

1.06e-0417319269a04271c51fae34f547db3206f9ff5857686e45c
ToppCellGlobus_pallidus-Endothelial-MURAL|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

TRABD2B ATF5 NTF3 TXLNB ENPEP PHLDB2

1.06e-041731926b77cd5dbda3a206922f20224f4e10a3bf712f7db
ToppCell3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ROBO4 ABI3 TMEM121 SAMD11 GRIP2 SAMD14

1.06e-041731926b57d14e2c2368304cb903562d06ce8228f53857c
ToppCellfacs-Lung-24m-Mesenchymal-myofibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ESPN TRABD2B MAP1A SHD GUCY1A1 SPON2

1.09e-041741926a7ade7372e83edd4e3983e77f8417b51f0b47340
ToppCelldroplet-Bladder-Unstain-18m-Hematologic-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ABI3 TOX EMB LCP2 SULT2B1 SAMD11

1.09e-041741926773329bb91b97578df138446cf62101dd0dad758
ToppCelldroplet-Marrow-BM-1m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ABI3 ANKZF1 DCAF5 C1orf226 MICAL2 PRDM16

1.12e-041751926c1c722db42da9b8a2a46e516ddb83d9be5e2e504
ToppCellCOVID-19-Heart-VSMC|COVID-19 / Disease (COVID-19 only), tissue and cell type

ZBTB7C NTF3 NHS PRDM16 ENPEP KCNT1

1.12e-0417519261125f0d3a5b2388fa77a820dea0288e824d84a82
ToppCell356C-Lymphocytic-NK_cells-NK_cell_A2|NK_cells / Donor, Lineage, Cell class and subclass (all cells)

OBSL1 LAMA5 GRB10 FCRL1 TXLNB PLK1

1.16e-041761926052b54c4337ca728974a106b6dbd3b72dd28eb23
ToppCell368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

TICRR RBBP8 KIF20A C1orf226 GUCY1A1 PLK1

1.20e-04177192626c25d10aa511b64cc7db43a8deea7b5d31bca96
ToppCelldroplet-Lung-nan-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

APC2 PTK2 NRXN3 GUCY1A1 AJUBA ENPEP

1.20e-0417719268684d47a547e2a06496f15e8da0200ecddc431e0
ToppCellPND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DZIP1L KIF20A GUCY1A1 AJUBA PLK1 SEZ6

1.20e-0417719262b63f0529ef73e0eede9b7ef1f08b0a0426a9c82
ToppCelldroplet-Lung-nan-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

APC2 PTK2 NRXN3 GUCY1A1 AJUBA ENPEP

1.20e-04177192665709bd546cb1ec6aa2ddd8b2adb46e174eb9a9a
ToppCell5'-Adult-LymphNode-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

JCAD ROBO4 LAMA5 AQP7B ITPKB LIPE

1.23e-041781926360d7a987f91d6d721487a921824057ec31a7332
ToppCellChildren_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor

ABI3BP NTF3 LAMA5 PTK2 SULT2B1 NHS

1.23e-041781926fba2e38c05cbf031e0c6d47b1602575fea734a57
ToppCellfacs-Brain_Non-Myeloid-Striatum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MAP1A CAMK2B NRXN3 PRRT3 IGSF9 KCNT1

1.23e-0417819261bddbc083c36657bd6910f7466126ab325e88176
ToppCellfacs-Brain_Non-Myeloid-Striatum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MAP1A CAMK2B NRXN3 PRRT3 IGSF9 KCNT1

1.23e-041781926a74e5a390cbeaca9de1fdb7b2a0e50783bd202dd
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c03-MKI67|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

TICRR ABCA3 E2F1 KIF20A GRID2IP SPON2

1.23e-041781926dbde3305e0c6a81593fe614e3f2e746b32cc16a7
ToppCelldroplet-Lung-LUNG-30m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TRABD2B APC2 HUNK PTK2 GUCY1A1 AJUBA

1.27e-04179192636ad18f52e175ab636ceaa3be81212fa362c96c1
ToppCelldroplet-Lung-LUNG-30m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TRABD2B APC2 HUNK PTK2 GUCY1A1 AJUBA

1.27e-041791926bfc226bcf0b93525992344f968268a261d86fcbf
ToppCellCOVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type

TRABD2B ZBTB7C NTF3 NHS PRDM16 ENPEP

1.27e-041791926a69ad6912b5c10bb9f9d800f724c792341e9bab1
ToppCellhuman_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

ZBTB7C COLGALT2 NRXN3 XIRP2 AUTS2 NHS

1.27e-04179192614fc8ccb6b215063d747643f47d780d2b237eb67
ToppCellPrimary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

NTF3 GRIN2D ANKRD55 NHS GRIP2 PRRT4

1.27e-04179192697ba67a856680f24846244c0b92c886cc0e79537
ToppCellFetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

ROBO4 GRAMD1A LAMA5 PLXND1 NEURL3 HELZ2

1.31e-041801926d8ef44710a77ad0fc03243428e5e1dc4d41200cb
ToppCellfacs-Brain_Non-Myeloid-Cerebellum-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IL16 EXPH5 CAMK2B NRXN3 SAMD14 KCNT1

1.31e-0418019266ac62bf1251978c8c12e715f7b73144fca619794
ToppCellControl-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations)

ABCA3 TOX HUNK MICAL2 AUTS2 ROS1

1.31e-041801926198b19e7910b4a8cc7e820c525ab357c7f99f578
ToppCelldroplet-Heart-nan-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TRABD2B NTF3 BCAS3 GUCY1A1 GRIP2 ENPEP

1.31e-04180192678fdcfb3fdbf36469cae78407cda5bd0996930d8
ToppCell10x5'-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-1|bone_marrow / Manually curated celltypes from each tissue

ASPHD1 KIF20A C1orf226 PRRG4 PLEC PLK1

1.35e-041811926ccd0ed30cea3fb41d34f28b3e8d80a94493bef3c
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ESPN TRABD2B GPT AQP7B NHS ENPEP

1.39e-0418219264a9c13932e7163fd37a3dcc4c6ca3bbea5372459
ToppCell10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-LMPP|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

NDOR1 TOX MAP1A BCAS3 SHD CARF

1.39e-04182192669b5cae6fe3bbb0fc60bd2f71b6cfa6cbb0b00ee
ToppCellBasal|World / shred by cell class for mouse tongue

TRABD2B RBBP8 LAMA5 PLEC AJUBA TNS1

1.43e-041831926c6729a207526ff4aa48176207b9353176f631fea
ToppCell5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

HEBP2 PLEKHA4 C2CD4A TESK1 NEURL3 SECTM1

1.43e-0418319262dde2fb48e7d31271c2f6b1dd74b2ab0b2cb520c
ToppCelldroplet-Kidney-nan-21m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ATF5 ZBTB7C OBSL1 CEP78 MICAL2 SAMD14

1.43e-041831926ad7421623e4c0c5ba02eec56e9bdae43ebb88d90
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Sncg-Sncg_Vip_Itih5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

LAMA5 GRID2IP FAM181B TNS1 TNS3

1.47e-041161925605bd4fdf547cc41783e99cd78425760ef6461ef
ToppCellPosterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Rorb|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

ESPN EXPH5 PLXND1 XIRP2 IGSF9

1.47e-0411619259c92e714e210a2f29a9e228653d4c990ec643c72
DrugDisopyramide [3737-09-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A

RALGDS BIN1 ATF5 MAP1A E2F1 TUT1 ZNF318 ANKZF1 GGA3 NALF2 PRRC2A

8.24e-07198188117035_UP
DrugAmikacin hydrate [37517-28-5]; Up 200; 6.6uM; PC3; HT_HG-U133A

ROBO4 IL16 CAMK2B SNED1 NRXN3 SULT2B1 BAZ2A OLIG2 TNS1 ENPEP

5.62e-06196188106715_UP
Drugcolcemid; Up 200; 11.7uM; MCF7; HT_HG-U133A_EA

DPYSL2 ABCA3 RAP1GAP2 GON4L ZNF318 PLXND1 PTK2 MAP2K3 PRRC2A

3.00e-0519018891103_UP
DrugQuinacrine dihydrochloride dihydrate [6151-30-0]; Up 200; 7.8uM; HL60; HG-U133A

CYLD DPYSL2 TANK E2F1 LCP2 TESK1 HIF1AN ATF7IP MAP2K3

3.12e-0519118891563_UP
Drug17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A

INPP5E LAMA5 E2F1 PLXND1 ANKZF1 BAZ2A MICAL2 ZFYVE26 PRRC2A

3.25e-0519218896986_DN
DrugGuanabenz acetate [23256-50-0]; Down 200; 13.8uM; PC3; HG-U133A

BIN1 TANK CAMK2B GRB10 TESK1 URGCP NFATC2IP PRRG4 SERTAD3

3.39e-0519318891961_DN
DrugNaltrexone hydrochloride dihydrate [16676-29-2]; Down 200; 9.6uM; HL60; HG-U133A

PEX6 SRSF11 ZNF318 CAMTA2 HIF1AN CIC YLPM1 PRRG4 TNS1

3.39e-0519318891363_DN
DrugPHA-00745360 [351320-33-7]; Down 200; 10uM; PC3; HT_HG-U133A

TOX ACACB BCAS3 GON4L E2F1 PLXND1 NRXN3 CSPP1 PLK3

3.53e-0519418894559_DN
DrugZuclopenthixol hydrochloride [633-59-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A

ASPHD1 E2F1 SRSF11 TUT1 ZNF318 ANKZF1 BAZ2A PLEC CSPP1

3.82e-0519618897356_DN
DrugBenzonatate [104-31-4]; Down 200; 6.6uM; MCF7; HT_HG-U133A

CYLD TANK EXPH5 TUT1 HIF1AN CIC PKN1 PLEC MAP2K3

3.82e-0519618891679_DN
DrugTriamterene [396-01-0]; Down 200; 15.8uM; HL60; HT_HG-U133A

CYLD PLXND1 HIF1AN KIF20A SPON2 PRRG4 SNX15 PLK1 CSPP1

3.82e-0519618891861_DN
DrugScoulerine [6451-73-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A

BIN1 TOX CDHR1 MAP3K14 GGA3 BAZ2A CARF HCFC1R1 PLEC

3.82e-0519618895536_UP
DrugTetracaone hydrochloride [136-47-0]; Down 200; 13.2uM; MCF7; HT_HG-U133A

C14orf93 TUT4 ACACB ABI3BP CAMK2B TUT1 BAZ2A PRRG4 SECTM1

3.82e-0519618892888_DN
DrugCefoperazone dihydrate; Down 200; 5.8uM; PC3; HT_HG-U133A

CYLD JCAD CNKSR1 BIN1 GON4L E2F1 ZNF318 CTDP1 MAP2K3

3.82e-0519618896323_DN
DrugSerotonin hydrochloride [153-98-0]; Up 200; 18.8uM; MCF7; HT_HG-U133A

REC8 IL16 ACACB NTF3 CAMK2B GPT BAZ2A TPP1 PLK3

3.98e-0519718893311_UP
DrugIsoniazid [54-85-3]; Down 200; 29.2uM; MCF7; HT_HG-U133A

BIN1 ASPHD1 EXPH5 E2F1 TUT1 CIC BAZ2A SDC3 MAP2K3

3.98e-0519718897197_DN
DrugSulfadimethoxine [122-11-2]; Down 200; 12.8uM; MCF7; HT_HG-U133A

CYLD C14orf93 GRB10 SLC12A8 CAMTA2 ITPKB CSPP1 PRRC2A PLK3

4.14e-0519818893441_DN
DrugSuramin sodium salt; Up 200; 10uM; MCF7; HT_HG-U133A

CYLD C14orf93 TUT4 GRB10 TPP1 CTDP1 TNS1 PLK3 SECTM1

4.14e-0519818897524_UP
DrugNorfloxacin [70458-96-7]; Up 200; 12.6uM; PC3; HT_HG-U133A

JCAD ROBO4 SETD1B MAP1A BCAS3 PEX6 SULT2B1 SDC3 PLK3

4.14e-0519818892090_UP
DrugFludrocortisone acetate [514-36-3]; Down 200; 9.4uM; PC3; HT_HG-U133A

C14orf93 E2F1 PLXND1 TEP1 BAZ2A MICAL2 PRRG4 TNS1 PLK3

4.14e-0519818893785_DN
DrugTiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Up 200; 6.4uM; MCF7; HT_HG-U133A

GRB10 TUT1 ZNF318 TEP1 BAZ2A SDC3 PLEC ENPEP PRRC2A

4.14e-0519818897011_UP
DrugPhentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A

C14orf93 BIN1 TUT4 GPT ITPKB YLPM1 PLEC TNS1 SECTM1

4.30e-0519918893860_DN
Drugtroglitazone; Up 200; 10uM; HL60; HT_HG-U133A

BIN1 IL16 ABCA3 ACACB CAMK2B CDHR1 SNED1 DOT1L SECTM1

4.30e-0519918896191_UP
DrugBacampicillin hydrochloride [37661-08-8]; Up 200; 8uM; MCF7; HT_HG-U133A

CYLD GRB10 E2F1 ZNF318 ATG2A CIC GGA3 PRRC2A PLK3

4.30e-0519918893273_UP
DrugMethamphetamine

DPYSL2 BIN1 NEURL2 ACACB MAP1A GPT OBSL1 PUSL1 PEX6 GON4L TUT1 CAMTA2 GRIN2D CIC KIF20A FAM193A BAZ2A ANKRD11 GRIP2 PLEC MAP2K3 PRDM16 PLEKHO1 TNS1 PLK3 CCDC116

9.13e-05140118826ctd:D008694
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A

SETD1B SLC12A8 ZNF804A URGCP KIF20A GUCY1A1 HCFC1R1 AP4M1

9.86e-0517318885950_DN
Drug5182598; Up 200; 25uM; MCF7; HT_HG-U133A_EA

RALGDS BIN1 ZNF318 ANKZF1 TPP1 SDC3 MAP2K3 PRRC2A

1.16e-041771888976_UP
DrugAzaguanine-8 [134-58-7]; Down 200; 26.2uM; PC3; HT_HG-U133A

TUT4 TANK EXPH5 ZNF318 NFATC2IP ANKRD11 ZFYVE26 PLK1

1.35e-0418118881791_DN
Drugwortmannin; Down 200; 1uM; MCF7; HT_HG-U133A_EA

BIN1 ASPHD1 E2F1 ITPKB SULT2B1 SDC3 MAP2K3 NALF2

1.81e-041891888869_DN
Drugvinblastine sulfate; Up 200; 0.1uM; PC3; HT_HG-U133A

JCAD BIN1 TOX CAMTA2 HIF1AN FAM193A YLPM1 HCFC1R1

2.02e-0419218887556_UP
DrugEtofenamate [30544-47-9]; Up 200; 10.8uM; MCF7; HT_HG-U133A

CYLD TUT4 ASPHD1 ACACB CIC SNED1 PRDM16 PLK3

2.02e-0419218884108_UP
DrugForskolin, from Coleus forskohlii; Down 200; 0.5uM; PC3; HT_HG-U133A

CYLD ABCA3 SETD1B TMEM121 KIF20A BAZ2A AP4M1 TNS1

2.02e-0419218887104_DN
DrugRapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A

CNKSR1 NDOR1 SETD1B YLPM1 CTDP1 PRRG4 ENPEP SECTM1

2.02e-0419218886958_UP
DrugProgesterone [57-83-0]; Down 200; 12.8uM; PC3; HT_HG-U133A

CYLD C14orf93 ACACB PEX6 E2F1 TMEM121 CSPP1 PLK3

2.09e-0419318886646_DN
DrugTocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A

NDOR1 CAMK2B CCL27 LIPE BAZ2A AUTS2 PRRG4 TNS1

2.17e-0419418884961_UP
DrugClorsulon [60200-06-8]; Down 200; 10.6uM; PC3; HT_HG-U133A

CYLD CNKSR1 BIN1 PEX6 E2F1 SLC12A8 ITPKB PRRG4

2.25e-0419518887264_DN
DrugNaringenine [480-41-1]; Up 200; 14.6uM; MCF7; HT_HG-U133A

BIN1 OBSL1 RAP1GAP2 GRB10 ATG2A CIC SULT2B1 SPON2

2.25e-0419518883278_UP
DrugST021200; Up 200; 10uM; PC3; HT_HG-U133A

JCAD BIN1 ABCA3 BAZ2A YLPM1 PKN1 PLK1 PLEKHO1

2.25e-0419518887559_UP
DrugMeptazinol hydrochloride [59263-76-2]; Up 200; 14.8uM; HL60; HT_HG-U133A

ABI3BP CAMK2B RAP1GAP2 SLC12A8 BAZ2A YLPM1 LTBP3 TNS1

2.25e-0419518882906_UP
DrugSpaglumic acid [4910-46-7]; Down 200; 13.2uM; HL60; HT_HG-U133A

EXPH5 E2F1 ANKRD55 CIC PTK2 TPP1 ZFYVE26 PKN1

2.25e-0419518882962_DN
DrugCyanocobalamin [68-19-9]; Up 200; 3uM; MCF7; HT_HG-U133A

CYLD RALGDS BIN1 SETD1B OBSL1 CAMTA2 CIC PRDM16

2.32e-0419618883252_UP
DrugICI182,780; Up 200; 1uM; MCF7; HT_HG-U133A

CNKSR1 BIN1 OBSL1 TEP1 TPP1 AUTS2 PLEC SECTM1

2.32e-0419618885926_UP
DrugLasalocid sodium salt [25999-20-6]; Up 200; 6.6uM; MCF7; HT_HG-U133A

NDOR1 MAP1A OBSL1 TEP1 GGA3 TPP1 SPON2 TNS1

2.32e-0419618883360_UP
Drugrosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A

SETD1B SLC12A8 CCL27 TESK1 SPON2 SDC3 TNS1 PLK3

2.32e-0419618885230_UP
DrugDebrisoquin sulfate [581-88-4]; Up 200; 9uM; MCF7; HT_HG-U133A

ASPHD1 LAMA5 TESK1 CDC42BPB CIC GGA3 BAZ2A MAP2K3

2.32e-0419618885288_UP
Drugaspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A

CAMTA2 ITPKB BAZ2A YLPM1 CTDP1 HCFC1R1 ENPEP PRRC2A

2.32e-0419618881629_DN
DrugHesperidin [520-26-3]; Down 200; 6.6uM; HL60; HT_HG-U133A

ATF5 PEX6 PLXND1 BAZ2A TPP1 SPON2 PKN1 PRRC2A

2.32e-0419618881294_DN
DrugBergenin monohydrate [477-90-7]; Down 200; 11.6uM; MCF7; HT_HG-U133A

ASPHD1 EXPH5 CAMTA2 ATG2A ANKZF1 MICAL2 MAP2K3 CSPP1

2.32e-0419618887224_DN
DrugXylazine [7361-61-7]; Up 200; 18.2uM; PC3; HT_HG-U133A

SNED1 SULT2B1 BAZ2A MICAL2 TPP1 AUTS2 PLEKHO1 TNS1

2.32e-0419618884066_UP
DrugPhthalylsulfathiazole [85-73-4]; Down 200; 10uM; MCF7; HT_HG-U133A

ASPHD1 PLXND1 TESK1 HIF1AN CIC ITPKB BAZ2A CSPP1

2.32e-0419618885249_DN
DrugZardaverine [101975-10-4]; Down 200; 15uM; MCF7; HT_HG-U133A

BIN1 EXPH5 E2F1 CIC TMEM121 SDC3 PLEC NALF2

2.32e-0419618884793_DN
DrugDiethylstilbestrol [56-53-1]; Down 200; 15uM; MCF7; HT_HG-U133A

E2F1 PLXND1 CIC ITPKB ZFYVE26 AP4M1 MAP2K3 CSPP1

2.32e-0419618883429_DN
DrugMesoridazine besylate [32672-69-8]; Down 200; 7.4uM; PC3; HT_HG-U133A

CNKSR1 BIN1 ACACB SLC12A8 ZNF318 KIF20A MAP2K3 CSPP1

2.32e-0419618887256_DN
DrugDichlorphenamide [120-97-8]; Down 200; 13.2uM; HL60; HT_HG-U133A

REC8 EXPH5 INPP5E E2F1 HIF1AN HCFC1R1 PLEC CSPP1

2.41e-0419718883027_DN
DrugRapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A

CYLD C14orf93 CAMK2B APC2 ZNF318 TEP1 YLPM1 ENPEP

2.41e-0419718886940_UP
DrugHarmaline hydrochloride dihydrate [6027-98-1]; Down 200; 14uM; MCF7; HT_HG-U133A

CYLD GRB10 ANKZF1 BAZ2A TPP1 CSPP1 ENPEP PLK3

2.41e-0419718884968_DN
Drugrofecoxib; Down 200; 10uM; HL60; HG-U133A

CYLD RALGDS CNKSR1 ACACB ZNF318 CAMTA2 KMT2D ANKRD11

2.41e-041971888371_DN
DrugCP-320650-01 [172079-28-6]; Down 200; 10uM; PC3; HT_HG-U133A

CYLD TOX YOD1 NRXN3 SDC3 PLEKHO1 CSPP1 TNS1

2.41e-0419718884557_DN
DrugFlavoxate hydrochloride [3717-88-2]; Down 200; 9.4uM; PC3; HT_HG-U133A

CNKSR1 BIN1 ZNF318 TMEM121 BAZ2A YLPM1 PKN1 CSPP1

2.41e-0419718886326_DN
Drug15(S)-15-methyl Prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A

CYLD MAP1A INPP5E CAMK2B GRB10 LIPE TPP1 CTDP1

2.41e-0419718887521_UP
Drugestradiol, USP; Down 200; 0.1uM; PC3; HT_HG-U133A

RALGDS CNKSR1 BIN1 ACACB ABI3BP E2F1 SULT2B1 MAP2K3

2.41e-0419718881208_DN
DrugEvoxine [522-11-2]; Up 200; 11.6uM; MCF7; HT_HG-U133A

BIN1 IL16 TOX MAP1A OBSL1 SNED1 GUCY1A1 PRDM16

2.41e-0419718886041_UP
DrugMycophenolic acid [24280-93-1]; Down 200; 12.4uM; MCF7; HT_HG-U133A

BIN1 ASPHD1 GRB10 ITPKB ANKRD11 PLK1 CSPP1 TNS3

2.41e-0419718884137_DN
DrugSpiramycin [8025-81-8]; Down 200; 4.8uM; HL60; HT_HG-U133A

BIN1 WWC3 INPP5E GON4L E2F1 ANKZF1 PLEC PRRC2A

2.41e-0419718882558_DN
DrugRapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A

ATF5 BCAS3 GRB10 ANKRD55 SNED1 HCFC1R1 TNS1 ENPEP

2.41e-0419718882702_DN
DrugICI 182,780; Up 200; 1uM; HL60; HT_HG-U133A

RAP1GAP2 CAMTA2 HIF1AN BAZ2A PRRG4 PLEC OLIG2 SECTM1

2.41e-0419718882665_UP
Drugvaldecoxib; Down 200; 10uM; PC3; HT_HG-U133A

JCAD RALGDS IL16 CAMK2B PLXND1 MICAL2 CTDP1 PLEKHO1

2.41e-0419718886408_DN
DrugIproniazide phosphate [305-33-9]; Down 200; 14.4uM; PC3; HT_HG-U133A

CYLD ACACB TUT1 PLXND1 HIF1AN YLPM1 SDC3 CSPP1

2.41e-0419718886359_DN
DrugICI 182,780; Down 200; 0.01uM; HL60; HT_HG-U133A

BCAS3 MAP3K14 RAP1GAP2 SLC12A8 PLXND1 HIF1AN URGCP HCFC1R1

2.41e-0419718882698_DN
DrugLaudanosine (R,S) [1699-51-0]; Up 200; 11.2uM; MCF7; HT_HG-U133A

IL16 NTF3 CAMK2B APC2 ZNF804A ANKRD55 TMEM121 BAZ2A

2.49e-0419818882890_UP
Drugtetraethylenepentamine pentahydrochloride; Down 200; 100uM; MCF7; HG-U133A

TUT4 INPP5E MAP3K14 E2F1 BAZ2A SLC34A1 AP4M1 SERTAD3

2.49e-041981888406_DN
DrugDiazoxide [364-98-7]; Down 200; 17.4uM; MCF7; HT_HG-U133A

ASPHD1 SLC12A8 TUT1 TESK1 CIC BAZ2A MICAL2 YLPM1

2.49e-0419818887168_DN
DrugFlurbiprofen [5104-49-4]; Down 200; 16.4uM; MCF7; HT_HG-U133A

CNKSR1 TUT4 MAP3K14 GRB10 ZNF318 TESK1 HIF1AN PLEKHO1

2.49e-0419818886472_DN
DrugHydrochlorothiazide [58-93-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A

CYLD BIN1 TUT4 E2F1 CIC TMEM121 PRRG4 PLK3

2.49e-0419818884970_DN
DrugTrimetazidine dihydrochloride [13171-25-0]; Up 200; 11.8uM; MCF7; HT_HG-U133A

BIN1 GPT SLC12A8 CCL27 CTDP1 TNS1 PRRC2A PLK3

2.49e-0419818885479_UP
DrugNeostigmine bromide [114-80-7]; Down 200; 13.2uM; MCF7; HT_HG-U133A

GON4L TUT1 ZNF318 TEP1 SULT2B1 BAZ2A CTDP1 PRRG4

2.49e-0419818883294_DN
Drugestradiol, USP; Up 200; 0.01uM; HL60; HT_HG-U133A

CYLD BIN1 ACACB EXPH5 LAMA5 TESK1 GGA3 BAZ2A

2.49e-0419818886200_UP
DrugGuanabenz acetate [23256-50-0]; Up 200; 13.8uM; MCF7; HT_HG-U133A

JCAD CNKSR1 BIN1 SLC12A8 ZNF318 TEP1 ITPKB PLK3

2.49e-0419818881544_UP
Drug(-)-MK 801 hydrogen maleate [77086-19-2]; Down 200; 11.8uM; HL60; HT_HG-U133A

RALGDS EXPH5 CAMK2B PEX6 E2F1 ANKRD55 SNX15 TNS1

2.49e-0419818883081_DN
DrugDimethisoquin hydrochloride [2773-92-4]; Down 200; 13uM; MCF7; HT_HG-U133A

EXPH5 GON4L ZNF318 HIF1AN TMEM121 NFATC2IP SDC3 PLEC

2.49e-0419818884791_DN
Drughaloperidol; Down 200; 10uM; MCF7; HT_HG-U133A_EA

CNKSR1 EXPH5 GRB10 SRSF11 TESK1 MAP2K3 CSPP1 ENPEP

2.49e-041981888983_DN
Drugestradiol, USP; Up 200; 0.1uM; PC3; HT_HG-U133A

NTF3 CDHR1 CCL27 CIC LIPE TPP1 OLIG2 TNS1

2.49e-0419818884432_UP
DrugMethacholine chloride [62-51-1]; Up 200; 20.4uM; MCF7; HT_HG-U133A

CYLD C14orf93 BIN1 IL16 CAMK2B TUT1 ANKZF1 PLK3

2.49e-0419818886248_UP
DrugAcebutolol hydrochloride [34381-68-5]; Down 200; 10.8uM; MCF7; HT_HG-U133A

CYLD ABI3BP SLC12A8 TUT1 TMEM121 TPP1 SDC3 PRRG4

2.49e-0419818884976_DN
DrugHydrocortisone base [50-23-7]; Up 200; 11uM; MCF7; HT_HG-U133A

CYLD CAMK2B E2F1 CIC TMEM121 PRRG4 PRDM16 CSPP1

2.49e-0419818885284_UP
DrugBenzydamine hydrochloride [132-69-4]; Down 200; 11.6uM; MCF7; HT_HG-U133A

CNKSR1 ASPHD1 GRB10 SLC12A8 TUT1 URGCP BAZ2A MAP2K3

2.49e-0419818887169_DN
DrugPF-00539758-00 [351321-34-1]; Down 200; 10uM; PC3; HT_HG-U133A

BIN1 NTF3 TUT1 YOD1 BAZ2A TPP1 SDC3 TNS1

2.49e-0419818886421_DN
DrugAtractyloside potassium salt [102130-43-8]; Up 200; 5uM; PC3; HT_HG-U133A

CYLD RALGDS NTF3 PLXND1 LIPE NRXN3 CARF TNS1

2.49e-0419818883695_UP
DrugAC1OAGKB

E2F1 IRF3 TEP1 PTK2 MAPK15 PKN1 ROS1 TNS1

2.49e-041981888CID006857406
DrugSulfanilamide [63-74-1]; Down 200; 23.2uM; MCF7; HT_HG-U133A

CNKSR1 ASPHD1 CAMK2B GON4L TUT1 ITPKB SDC3 AP4M1

2.58e-0419918886810_DN
Drugsulindac sulfone; Down 200; 50uM; MCF7; HG-U133A

ROBO4 ACACB E2F1 TUT1 CIC NFATC2IP PLEC TNS1

2.58e-041991888309_DN
DrugBuflomedil hydrochloride [35543-24-9]; Up 200; 11.6uM; MCF7; HT_HG-U133A

BIN1 ATF5 MAP1A GRB10 CCL27 ITPKB BAZ2A PRRC2A

2.58e-0419918883274_UP
DrugMethoxy-6-harmalan [3589-73-9]; Down 200; 18.6uM; PC3; HT_HG-U133A

CYLD ABCA3 TOX ANKZF1 YLPM1 SDC3 PRRG4 TNS1

2.58e-0419918886355_DN
DrugLysergol [602-85-7]; Up 200; 15.8uM; HL60; HT_HG-U133A

REC8 C14orf93 SLC12A8 TEP1 CIC MICAL2 PKN1 TNS1

2.58e-0419918881325_UP
DrugHeliotrine [303-33-3]; Up 200; 12.8uM; MCF7; HT_HG-U133A

BIN1 NDOR1 ACACB CAMK2B ANKRD55 KMT2D NRXN3 AUTS2

2.58e-0419918883615_UP
DrugTicarcillin sodium [4697-14-7]; Up 200; 9.4uM; MCF7; HT_HG-U133A

ROBO4 RALGDS TANK GRB10 PLXND1 TMEM121 ITPKB ENPEP

2.58e-0419918887185_UP
DrugAspartic acid, N-acetyl (R,S) [997-55-7]; Up 200; 22.8uM; MCF7; HT_HG-U133A

REC8 CAMTA2 CIC GGA3 BAZ2A TPP1 CTDP1 TNS1

2.58e-0419918883265_UP
DrugMethiothepin maleate [19728-88-2]; Down 200; 8.4uM; PC3; HT_HG-U133A

BIN1 MAP1A PEX6 ANKZF1 SDC3 HCFC1R1 CSPP1 TNS1

2.58e-0419918886312_DN
DrugFlurbiprofen [5104-49-4]; Up 200; 16.4uM; MCF7; HT_HG-U133A

CYLD CNKSR1 SETD1B CAMK2B BAZ2A SDC3 NALF2 PLK3

2.58e-0419918885269_UP
DrugProbenecid [57-66-9]; Up 200; 14uM; HL60; HT_HG-U133A

ABI3BP GPT SLC12A8 TUT1 CCL27 TESK1 SULT2B1 YLPM1

2.58e-0419918882464_UP
DiseaseIntellectual Disability

RALGDS CNKSR1 INPP5E CAMK2B APC2 PEX6 GON4L GRIN2D CIC TPP1 SERAC1 FUCA1 AP4M1 TET3

7.64e-0744718114C3714756
DiseaseProfound Mental Retardation

RALGDS CNKSR1 INPP5E PEX6 GON4L CIC AP4M1

2.51e-051391817C0020796
DiseaseMental Retardation, Psychosocial

RALGDS CNKSR1 INPP5E PEX6 GON4L CIC AP4M1

2.51e-051391817C0025363
DiseaseMental deficiency

RALGDS CNKSR1 INPP5E PEX6 GON4L CIC AP4M1

2.51e-051391817C0917816
Diseaseautosomal recessive nonsyndromic deafness 36 (implicated_via_orthology)

ESPN ESPNL

3.74e-0521812DOID:0110494 (implicated_via_orthology)
Diseaseeosinophil count

ZBTB7C ST20-AS1 EMB RBBP8 MAP3K14 RAP1GAP2 GRB10 LCP2 ZDHHC8 ITPKB FAM193A NEURL3 ATF7IP SEC16A HELZ2 ANKRD11 SDC3 FUCA1 LTBP3 PLEC AJUBA OLIG2 TET3

4.41e-05148818123EFO_0004842
DiseaseMalignant neoplasm of breast

ABCA3 TANK APC2 E2F1 ZNF318 COLGALT2 GRIN2D TESK1 CIC GGA3 KMT2D LIPE FAM217B NHS ZFYVE26 TNS1 ENPEP PRRC2A

1.16e-04107418118C0006142
Diseasebrain measurement, neuroimaging measurement

DPYSL2 PRR23A TANK GRB10 SLC12A8 HIF1AN PTK2 CARF IGSF9 PLEC PRDM16 TNS1

1.61e-0455018112EFO_0004346, EFO_0004464
DiseaseAdenocarcinoma of large intestine

CAMK2B CDC42BPB UBR5 PKN1 ROS1

3.20e-04961815C1319315
Diseaserestrictive cardiomyopathy (is_implicated_in)

KIF20A MAP2K3

5.52e-0461812DOID:397 (is_implicated_in)
Diseaselung small cell carcinoma (is_implicated_in)

E2F1 PTK2 KMT2D

6.64e-04281813DOID:5409 (is_implicated_in)
Diseaseepidermolysis bullosa simplex (is_implicated_in)

EXPH5 PLEC

7.70e-0471812DOID:4644 (is_implicated_in)
Diseaseimmature platelet measurement

JCAD DCAF5 BAZ2A PLEC PRDM16

8.54e-041191815EFO_0803541
DiseaseAutism Spectrum Disorders

CIC NRXN3 ANKRD11 TET3

1.88e-03851814C1510586
Diseasegastric adenocarcinoma (is_implicated_in)

KMT2D UBR5

1.98e-03111812DOID:3717 (is_implicated_in)
Diseasemyeloid white cell count

JCAD BIN1 SETD1B ST20-AS1 INPP5E GRAMD1A MAP3K14 CIC KANSL2 GUCY1A1 MICAL2 DOT1L TNS3 SERTAD3

2.00e-0393718114EFO_0007988
Diseasebody surface area

TICRR GRB10 COLGALT2 HIF1AN NRXN3 UBN1 ANKRD11 AUTS2 LTBP3 PLEC DOT1L

2.17e-0364318111EFO_0022196
Diseasebrain disease (is_implicated_in)

IRF3 MFF

2.37e-03121812DOID:936 (is_implicated_in)
Diseaseovary epithelial cancer (is_marker_for)

PLK1 PLK3

2.79e-03131812DOID:2152 (is_marker_for)
DiseaseAlzheimer disease

BIN1 ABI3 PRICKLE1 NTF3 BCAS3 PEX6 ANKRD55 NRXN3 PLEC

3.18e-034851819MONDO_0004975
DiseaseAcute Confusional Senile Dementia

DPYSL2 BIN1 ABI3 TPP1

3.28e-03991814C0546126
DiseaseAlzheimer's Disease, Focal Onset

DPYSL2 BIN1 ABI3 TPP1

3.28e-03991814C0750900
DiseaseAlzheimer Disease, Early Onset

DPYSL2 BIN1 ABI3 TPP1

3.28e-03991814C0750901
DiseasePresenile dementia

DPYSL2 BIN1 ABI3 TPP1

3.28e-03991814C0011265
DiseaseAlzheimer Disease, Late Onset

DPYSL2 BIN1 ABI3 TPP1

3.28e-03991814C0494463
DiseaseFamilial Alzheimer Disease (FAD)

DPYSL2 BIN1 ABI3 TPP1

3.40e-031001814C0276496
DiseaseAlzheimer's Disease

DPYSL2 BIN1 ABI3 TPP1

3.52e-031011814C0002395
Diseasecortical thickness

DPYSL2 PRR23A INPP5E ESPNL SLC12A8 ZNF318 PLXND1 HIF1AN ZNF469 UBN1 YLPM1 AUTS2 IGSF9 PLEC TNS1

3.71e-03111318115EFO_0004840
DiseaseDiuretic use measurement

TICRR BCAS3 ZNF318 GUCY1A1 ENPEP

3.96e-031691815EFO_0009928
Diseasemean reticulocyte volume

CAD GRB10 ZNF318 ZNF469 IFT52 ATF7IP TONSL HELZ2 PLK1 MAP2K3 PRDM16 SERTAD3

3.98e-0379918112EFO_0010701
Diseaselung small cell carcinoma (is_marker_for)

E2F1 PTK2

4.24e-03161812DOID:5409 (is_marker_for)
DiseaseSchizoaffective disorder-bipolar type

ZNF804A NRXN3

4.24e-03161812EFO_0009965
Diseasevitamin C measurement

BCAS3 SLC34A1

4.24e-03161812EFO_0600003
Diseaseintraocular pressure measurement

JCAD BCAS3 CAMTA2 MFF ZNF469 LTBP3 NALF2 PRDM16 TNS1

4.35e-035091819EFO_0004695
Diseasemortality

JCAD RAP1GAP2 NT5C1B NRXN3 AUTS2

4.37e-031731815EFO_0004352
DiseaseAgents acting on the renin-angiotensin system use measurement

TICRR BCAS3 ZNF318 GUCY1A1 AUTS2 PRDM16 ENPEP

4.78e-033351817EFO_0009931
DiseaseSjogren's syndrome (implicated_via_orthology)

MAP3K14 E2F1

4.79e-03171812DOID:12894 (implicated_via_orthology)
Diseaseschizophrenia, inflammatory bowel disease

TOX IRF3

5.37e-03181812EFO_0003767, MONDO_0005090
Diseaseimmature platelet fraction

DCAF5 BAZ2A PLEC PRDM16

5.41e-031141814EFO_0009187
Diseasemonocyte percentage of leukocytes

SEMA6C BIN1 ST20-AS1 INPP5E MAP3K14 ANKRD55 CTDP1 SEC16A PRDM16 SERTAD3 SECTM1

5.66e-0373118111EFO_0007989
Diseasebreast cancer (is_marker_for)

TUT4 BCAS3 KMT2D MAPK15 MAP2K3

5.79e-031851815DOID:1612 (is_marker_for)
DiseaseAntihypertensive use measurement

ZNF318 GUCY1A1 AUTS2 PRDM16 ENPEP PHLDB2

6.04e-032651816EFO_0009927
Diseaseplatelet crit

JCAD MAP1A BCAS3 EXPH5 MAP3K14 LAMA5 ZNF318 DQX1 YLPM1 PRRG4 PLEC DOT1L PRDM16

6.07e-0395218113EFO_0007985

Protein segments in the cluster

PeptideGeneStartEntry
SLQPPASPQLPRSLD

NT5C1B

176

Q96P26
RPPLDQPLELAPLTT

C2orf42

556

Q9NWW7
ALLDLVVSPPAPTDP

GPT

356

P24298
PPLTPETLQTLFSAP

ERFL

161

A0A1W2PQ73
LPIRQEPSSFRAVPP

CTDP1

796

Q9Y5B0
FEPSLRTLPSIGPPS

ERICH6

231

Q7L0X2
LLSPDPTAAFLLPPS

CCL27

16

Q9Y4X3
NSPESSLLPRAPALP

CDHR1

781

Q96JP9
FPTSLEPTSDLPPLG

CCDC116

336

Q8IYX3
PPDQASTRLPAELEP

ANKRD11

2191

Q6UB99
PPQEELPTRVSSPVF

RBBP8

316

Q99708
TRALPLPQSLPPDFR

AJUBA

96

Q96IF1
LPQSLPPDFRLEPTA

AJUBA

101

Q96IF1
LRPSADPIFEPRQLP

BAZ2A

1481

Q9UIF9
IPPQDPASPSFTLLS

ARGFX

26

A6NJG6
PFRSINIPEPVLPSE

ARHGEF33

141

A8MVX0
FAEPLEIRPSPPTSR

CAMTA2

301

O94983
TTSLFPLFPNPGPRE

ABCA3

181

Q99758
LLSQESRTEPTRPPP

ANKRD55

316

Q3KP44
DARIPLPLDSFPVPV

CEP78

606

Q5JTW2
PSPVLQPRDPSSTLE

DOT1L

901

Q8TEK3
PLPTNESQPLSLFPT

BCAS3

911

Q9H6U6
LSETRPEALPPPSSN

FAM193A

561

P78312
LDLPSFAPPAQLAPT

ATG2A

1006

Q2TAZ0
ITVSDPPFDTQPRPD

GRAMD1A

706

Q96CP6
LSDDLPSPLPFRLFP

AP4M1

286

O00189
PSFDLPQPPVLDTLD

ATF5

146

Q9Y2D1
VPPPTDSARLLNTSP

MTUS2

571

Q5JR59
PSPVSLPLDRPQETR

RCC1L

161

Q96I51
SVDPRLPSPFDIPQI

REC8

141

O95072
LQRNFPDPDTPPLTI

YOD1

271

Q5VVQ6
EVFQRPPTLEELSPP

ABI3

251

Q9P2A4
TPISFETPSNPPLAR

ACACB

631

O00763
RTLQVALPSTPAEPP

DZIP1L

556

Q8IYY4
ASDPELQPAERPLPS

OBSL1

106

O75147
FPPPPLLATRRSLED

ESPNL

341

Q6ZVH7
SFLNPPLPPSIDDRD

MAP1A

2451

P78559
PLDFLDLERPPTTPQ

MFF

126

Q9GZY8
PRPPPALSLDIASDS

INPP5E

191

Q9NRR6
RSPRAPEPALEPESL

NPW

116

Q8N729
SFPTRPIPRLSQSDP

HIF1AN

36

Q9NWT6
PSRLLLQPSPQRADP

IGLJ1

1

A0A0A0MT76
PLSPDPTTPDFLNSL

DPYSL2

306

Q16555
PRQTLDALLPPDTSP

MAPK15

261

Q8TD08
IPSEQQFDPPRPLES

HEBP2

111

Q9Y5Z4
NPSRDPPPSIFTFIA

AQP7B

231

A0A075B734
FLPDLPSAPFVPRDA

ASPHD1

191

Q5U4P2
PESPQEELLSRPAPA

JCAD

1121

Q9P266
FQPDSPLPSVSPALS

ESPN

686

B1AK53
PPETDPPATNLTRAL

LMLN

606

Q96KR4
LINPPPDTRLEPSDI

KCNT1

1176

Q5JUK3
ELETPCLTLSPSPFP

CARF

381

Q8N187
PTSPQDCPRTLLSPL

PLXND1

746

Q9Y4D7
LRVLEPFPTETPPLA

PEX6

6

Q13608
DVLPPPSQLPSARER

CSPP1

1116

Q1MSJ5
DLSDSERIPIPPSPL

FAM217B

96

Q9NTX9
FISLPQLPPSAVPAE

FUCA1

441

P04066
SIASSRLPQESPPLP

IL16

556

Q14005
RLPQESPPLPESRDS

IL16

561

Q14005
EDPLATPPIATRAPS

NRXN3

1346

Q9Y4C0
TEPQLRAPSPDPDLV

AUTS2

311

Q8WXX7
ELDTDLFPRPRSPSP

DCAF5

541

Q96JK2
LFPRPRSPSPEDESS

DCAF5

546

Q96JK2
AAETPALELPLPSVP

NELFB

561

Q8WX92
PPVSLSTPDPLFQLS

LMLN2

611

A0A1B0GTW7
SDNQRRLSPPFPLEP

EXPH5

1746

Q8NEV8
LQPPSGTELSPFSPI

GGA3

656

Q9NZ52
QSLQRLFEPTTPAPP

NALF2

151

O75949
LRPPDSLSRAPAEFP

NALF2

166

O75949
LLDPRANPSQPPSDL

ENPEP

561

Q07075
PLRARNLPPSFFTEP

FAM181B

221

A6NEQ2
RPPTAVDPDAEPTLL

LAMA5

1266

O15230
DLPLSAVPPSQEERP

CDC42BPB

1606

Q9Y5S2
IQPDLSDRPTPSDPQ

PCDHGB3

671

Q9Y5G1
SPRVLLSDSTPLEPP

NTF3

101

P20783
EAAAPSRPPTLLVEP

NEURL2

131

Q9BR09
SFLELEAPPLPQPRV

DQX1

391

Q8TE96
LQPREPDVSSPTRLP

NDOR1

276

Q9UHB4
LEELPPATPSPRLAL

SLC34A1

616

Q06495
DDLSSPPSALPTPQF

PRICKLE1

796

Q96MT3
PARTQPSLIADETPP

APC2

1561

O95996
ELATLSQPPRSATPP

APC2

1851

O95996
LPTLQPAVFPPSFRE

IFT52

331

Q9Y366
LDLESEPTPEPQPRS

GRID2IP

481

A4D2P6
PDLLLFATPQAPRPT

E2F1

61

Q01094
PSPADPRVLSLLSAP

ANKZF1

516

Q9H8Y5
DPLRSLPSPLPQEFT

FCRL1

341

Q96LA6
RSVLQETFPRLDPPP

C1orf226

106

A1L170
PSDRLPSAEAQLLPP

C14orf93

476

Q9H972
PSADRPLEASLPPLQ

HUNK

681

P57058
ALPAVPPEARTSFPL

GON4L

1071

Q3T8J9
PQPQRLPPEAASTSL

ATF7IP

1146

Q6VMQ6
PDLPPSRSAVEIAPT

LTBP3

556

Q9NS15
PELELALTPARAPSP

RALGDS

271

Q12967
PPSPLLFDPSLTLED

KANSL2

421

Q9H9L4
RTSSLPAIPNPFPEL

GRB10

131

Q13322
FSPALPPLRSPCSEL

HCFC1R1

86

Q9NWW0
SPPSPLFLEAPSRQA

ARRDC1-AS1

71

Q9H2J1
APDSPFTSPPLREEI

EMB

36

Q6PCB8
ISTDFDRSSPPLQPP

CYLD

391

Q9NQC7
LPPPTSLDTVPSRDE

COLGALT2

611

Q8IYK4
LLFPSNRETLPDPCP

HELZ2

1756

Q9BYK8
LSSPPLVCFIEPDSP

GRIP2

481

Q9C0E4
LDLDFDPLPPVTSPV

BIN1

391

O00499
PRALPRPATTQEPDI

SDC3

256

O75056
SPPSFPVEISDRLPA

SLC12A8

511

A0AV02
LLPPDTLPLRPAVDS

SBK3

211

P0C264
APSLSELDLRPPSPI

PRRT3

796

Q5FWE3
ELRPLPPSPIEDSQL

C3orf56

206

Q8N813
PPSSRVPFPERLEAE

C2CD4A

231

Q8NCU7
PPRSVPPTDFSQLID

LARP1B

301

Q659C4
LSPSTPSDVNFLLPP

LIPE

901

Q05469
EEATPSPSPPLKRQF

MICAL2

766

O94851
EPLPLSSLEPAPARN

MAP3K14

741

Q99558
LRSPSLDNPTPFPNL

IRF3

171

Q14653
PNPTPPRNLDSRTFI

MAP2K3

36

P46734
RPPFPPEVLAEALNT

PUSL1

86

Q8N0Z8
SPLPAPSPRISDILN

CAMK2B

441

Q13554
ESDLRFFLLPPPLPS

SERAC1

186

Q96JX3
DATLPDRPLSPPLTA

RAP1GAP2

36

Q684P5
RSPQPAERVDPALPL

SHD

221

Q96IW2
PSLEPNTSLEREPRP

SULT2B1

331

O00204
FIPPAPVLPSRDNEI

SPON2

251

Q9BUD6
FDPEFRLLEPVPSSP

PRR23A

216

A6NEV1
ETLRSNPPPSLAITP

NHS

1121

Q6T4R5
DLFTPLSRPPSPLSL

PLEKHA4

231

Q9H4M7
FLFPPAESLSPEEPR

ITPKB

56

P27987
PQEISPPPTANLDRS

PTK2

906

Q05397
GLDLSLSPRPDSPQP

PPP1R35

41

Q8TAP8
NFRSPPPTLSDPILR

PRDM16

931

Q9HAZ2
FTATPAEPRPLTSPL

PRRC2A

796

P48634
SFPLLDPSDAPFPSL

TANK

341

Q92844
SFSERELPQPPPLLS

SAMD11

286

Q96NU1
RRSLDEDEPPPSPLT

SAMD14

106

Q8IZD0
ELSPPQPLFRPRSEF

SETD1B

1661

Q9UPS6
RPSSPEPDDLFLPAR

OLIG2

11

Q13516
EAPTLSPPRDARPLT

PKN1

911

Q16512
EPPDSLAPPSSQAFL

TNS3

1006

Q68CZ2
EFLDLDNSPLSPPSP

NFATC2IP

191

Q8NCF5
DELLSDLTRTPPPPS

PHLDB2

541

Q86SQ0
TLQLRAEEPPTPALP

PLEKHO1

286

Q53GL0
PPSPRDEIFLTPNLS

ROBO4

936

Q8WZ75
APETPTQPPRFSELV

SNED1

1236

Q8TER0
PPQPDPVFLEALSSR

SERTAD3

126

Q9UJW9
PEFILTQSPPELAPA

ANHX

316

E9PGG2
ELPEFRPEEVLPSPT

CIC

1361

Q96RK0
PSLSLAPLSPRAPSE

CNKSR1

306

Q969H4
VTAFSQSPELPSPPR

XIRP2

291

A4UGR9
FSELPTPDTPVNPLD

URGCP

171

Q8TCY9
VPDLTPPNPARSLFA

PLK3

331

Q9H4B4
PPELSQRATLDTVPP

TICRR

1361

Q7Z2Z1
TPDSEPTPRPLALVF

SECTM1

211

Q8WVN6
SLRPLEEDTPSPLAP

TEP1

876

Q99973
PPPFTPSLLEQEVRA

MISP3

146

Q96FF7
LPIPSNLFVPTPDAE

SEC16A

2221

O15027
ELRLFPPDDSPLPVS

SRSF11

61

Q05519
LEPPTPTDLPSARAR

ST20-AS1

66

Q8NBB2
RIEDSTTASPPPLPL

TRABD2B

446

A6NFA1
PDTAPLPVPANIRFS

KIF20A

286

O95235
SPQSLPPASPLLEDR

TUT1

301

Q9H6E5
TPSSLLFDPETSPPL

TONSL

681

Q96HA7
VRDFPPPALSLELQP

TMEM121

271

Q9BTD3
SFSEAEPQLPPAPVR

TNS1

621

Q9HBL0
VASRPSPQPLAETPI

TNS1

676

Q9HBL0
AETPIPSLPEFPRAA

TNS1

686

Q9HBL0
PPPSSPAQEALDLLF

SNX15

176

Q9NRS6
PPEAPRPLFFLTLEA

PRRT4

336

C9JH25
DLPPASASRSVPIPL

SEMA6C

591

Q9H3T2
PFTPSPLPRLANQDS

SEZ6

101

Q53EL9
APETVPSAPENPRIF

ROS1

1036

P08922
LPRAAALERTEPSPP

TESK1

541

Q15569
FRRPEEAALSPLPPS

PRRG4

166

Q9BZD6
PEPSPAAPTLRSELE

PLEC

1191

Q15149
PAPSTRPLLSSEVPQ

TET3

316

O43151
LFAPSPSRDSLLPPT

TET3

666

O43151
FLRSPETPPVSPRES

IGSF9

966

Q9P2J2
RPLPTTVQAASPLPE

PRR33

81

A8MZF0
SSLPFLDPNARPLVP

CAD

146

P27708
SQFRERDIPSLPPLP

YLPM1

1321

P49750
PSLPPFLCPDLEEQS

NEURL3

91

Q96EH8
PLPREDPLTSPSRAQ

ZNF469

2101

Q96JG9
TPLTREDRPALQEPP

ZNF333

121

Q96JL9
PISRVDTFPQPLAAP

FTSJ1

296

Q9UET6
IPDRRPSLSPFAPDF

ZBTB7C

241

A1YPR0
PPPASSLQSPLNFLA

UBN1

726

Q9NPG3
TDLPEPPPSLTVQRD

ZDHHC8

696

Q9ULC8
LIPSRDSESPLPPLT

TXLNB

546

Q8N3L3
QPRATLAPSETPFVP

ABI3BP

421

Q7Z7G0
QEESELRSLPPPSPA

TUT4

336

Q5TAX3
EALELPEPRTPPLSS

ZFYVE26

1096

Q68DK2
PEPRTPPLSSLVEQA

ZFYVE26

1101

Q68DK2
PSLESEDFNIPPITP

TOX

61

O94900
VRPPPPLSSVFSEQA

ZNF318

1536

Q5VUA4
SPLDTPFLPASRDSP

WWC3

466

Q9ULE0
RPRELESPVPDSPQL

TEX12

16

Q9BXU0
EELFSVEPLPPRPSS

UBR5

1511

O95071
LPEEFLRPPSTSVAP

ZNF804A

791

Q7Z570
IPPRFSIAPSSLDPS

PLK1

321

P53350
FPPTSSLRQRPEPQV

TPP1

176

O14773
PRSREELPPNFPSEI

GUCY1A1

636

Q02108
ASRLFPPFEESPLSP

KMT2D

596

O14686
LDVRQLSAPPPEEPS

KMT2D

4901

O14686
PPLDRSLAPFDREPF

LCP2

241

Q13094
DLPPPAPTSRSLEDL

GRIN2D

1261

O15399